Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Amryt Pharma Plc (NASDAQ:AMYT) has presented long-term from the 2nd year open-label extension (OLE) of its Phase 3 OPTIMAL trial of Mycapssa (octreotide capsules in acromegaly.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
- The trial compared long-term safety and efficacy data of Mycapssa to placebo for maintenance of biochemical response in patients with acromegaly, a hormonal disorder in which the pituitary gland produces too much growth hormone during adulthood.
- The data demonstrated that 100% of evaluable patients who entered the 2nd year OLE phase of the study as responders - insulin-like growth factor 1 (IGF-1) within normal limits - maintained their long-term biochemical response at the end of the study.
- Related: Amryt Pharma's Q4 FY21 Sales, FY22 Guidance Shy Of Street Consensus.
- IGF-1 levels were stably maintained within normal limits at the end of the OLE period.
- Growth hormone (GH) levels also improved at the end of the OLE period.
- The long-term safety profile of Mycapssa during the OLE was consistent with that observed in prior studies.
- Price Action: AMYT shares are up 1.97% at $7.76 during the market session on the last check Wednesday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.